Robert Motzer
MD
Jack and Dorothy Byrne Chair in Clinical Oncology
👥Biography 个人简介
Robert Motzer is one of the most influential figures in kidney cancer who led the landmark trials establishing sunitinib and nivolumab-ipilimumab as standards of care. His IMDC prognostic model has guided treatment decisions worldwide. He continues to lead pivotal trials including belzutifan combinations and next-generation IO approaches for RCC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Robert Motzer 的研究动态
Follow Robert Motzer's research updates
留下邮箱，当我们发布与 Robert Motzer（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment